The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

Despite relentless FII outflows, select Indian stocks saw increased foreign interest in the December ended —here’s where ...

Merilog is expected to be available in July 2025, and Sanofi will provide Merilog to patients for $35 or less for a 30-day ...

First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Cross-industry collaboration is key to fighting rising costs for consumers. The Fast Company Impact Council is a private ...

Each Soliqua 100/33 pen contains 3 milliliters (mL) of solution, with 300 units of insulin and 99 micrograms (mcg) of lixisenatide per pen. (This is 100 units of insulin and 33 mcg of lixisenatide ...

Insulin solutions must be remixed every 24 hours to maintain potency. Notify the physician if the infusion rate exceeds 16 units/hr or if hypoglycemia has not resolved after 50 mL of 50% dextrose ...